Resumen:
Deregulation of the mechanistic target of the rapamycin (mTOR) pathway plays an important role in cancer genesis and progression,
making it an attractive target for cancer treatment. Disrupting the mTOR pathway contributes to uncontrolled cell growth,
increased proliferation, and enhanced cell survival, all of which are hallmarks of cancer. The findings imply that the deregulation
of the mTOR pathway in cancer provides a compelling basis for therapeutic treatments. Phytochemicals such as flavonoids
and polyphenols have been shown to play a key role in suppressing different kinases implicated in PI3K/AKT/mTOR signaling
cascades. A thorough study of the molecular connections between bioactive substances, mTOR signaling, and autophagy activation
can lead to the creation of personalized treatments that work better and have fewer side effects. Finding out how important
it is to target the mTOR pathway and how to use bioactive chemicals from plants to treat cancer are both important discoveries
that could lead to more precise medicine and the development of effective cancer drugs. Finally, targeting mTOR pathways using
plant-derived
chemicals may be a promising therapy strategy for cancer. This review tries to summarize putative plant bioactive
chemicals that act on malignancies via mTOR signaling pathways. Furthermore, the paper discusses the role of the mTOR pathway
in cancer, specifically its influence on cell growth, proliferation, and survival.
